Business Context and Reporting Period
This Form 8-K filing by Aadi Bioscience, Inc. (trading symbol: AADI) reports on the results of its Annual Meeting of Stockholders held on June 11, 2024. The filing details the voting outcomes for three specific proposals presented to shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results rather than financial performance.
Material Changes and Voting Results
At the Annual Meeting, 15,104,613 shares were present, representing approximately 62% of the voting power. The following proposals were voted upon:
- Proposal 1: Election of Directors. Two Class I directors were elected for terms expiring in 2027.
- Caley Castelein, M.D.: 9,946,929 votes For; 1,906,524 votes Withheld.
- Neil Desai, Ph.D.: 8,171,610 votes For; 3,681,843 votes Withheld.
- Proposal 2: Advisory Executive Compensation. The compensation of named executive officers was approved on an advisory basis.
- For: 8,971,541 votes.
- Against: 2,599,458 votes.
- Abstentions: 282,454 votes.
- Proposal 3: Ratification of Auditors. The appointment of BDO USA LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified.
- For: 13,464,651 votes.
- Against: 635,298 votes.
- Abstentions: 1,004,664 votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Important Facts for Investors to Verify
- Verify the definitive proxy statement filed on April 26, 2024, for detailed biographies of the elected directors and the full executive compensation table.
- Confirm the total number of outstanding shares as of the record date (April 18, 2024) to contextualize the 62% participation rate.
- Review the company's most recent 10-K or 10-Q filings for financial metrics, as this 8-K contains no financial data.